Ditchcarbon
  • Customers
  1. Organizations
  2. ImmunoPrecise Antibodies Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
CA
updated 5 months ago

ImmunoPrecise Antibodies Ltd.

Company website

ImmunoPrecise Antibodies Ltd., often referred to as IPA, is a leading biotechnology company headquartered in Canada. Founded in 2010, the company has established itself as a key player in the field of antibody discovery and development, with significant operations across North America and Europe. Specialising in custom monoclonal antibodies, ImmunoPrecise offers a unique suite of services, including hybridoma development and phage display technologies, which set them apart in the competitive landscape. The company has achieved notable milestones, such as the successful launch of its proprietary antibody discovery platform, enhancing its market position. With a commitment to innovation and quality, ImmunoPrecise Antibodies Ltd. continues to support the biopharmaceutical industry, providing essential tools for research and therapeutic development.

DitchCarbon Score

How does ImmunoPrecise Antibodies Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

ImmunoPrecise Antibodies Ltd.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

ImmunoPrecise Antibodies Ltd.'s reported carbon emissions

ImmunoPrecise Antibodies Ltd., headquartered in Canada, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As there are no emissions data or reduction initiatives available, it is important to note that the company may still be in the early stages of developing its climate strategy. In the broader context of the biotechnology industry, many companies are increasingly focusing on sustainability and carbon reduction, often setting Science-Based Targets (SBTi) to align with global climate goals. However, without specific commitments or data from ImmunoPrecise Antibodies Ltd., it is unclear how they plan to address climate change or carbon emissions in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ImmunoPrecise Antibodies Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ImmunoPrecise Antibodies Ltd. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ImmunoPrecise Antibodies Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Genscript Biotech Corporation

CN
•
Research and development services (73)
Updated 4 days ago

Antibody Solutions Inc.

US
•
Research and development services (73)
Updated 14 days ago

Genovac GmbH

DE
Updated 14 days ago

Abveris Inc.

US
•
Chemicals nec
Updated 14 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy